Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Kenya: US Delegation Backs Fight Against Period Poverty in Kenyan Schools

[Capital FM] Kisii -- A delegation of US-based leaders and humanitarian advocates is in Kenya for a week-long outreach programme aimed at tackling period poverty among schoolgirls and promoting menstrual dignity in schools.

A US delegation of leaders and humanitarian advocates is currently in Kenya for a week-long mission to combat period poverty in schools and promote menstrual dignity among schoolgirls, according to the source. The delegation has been visiting schools throughout the country to provide sanitary products, educate girls on menstrual hygiene, and offer counseling and mental health support.

Dr Leslie Latimore-Lorfils, a leadership strategist and former senior military officer, emphasized that period poverty extends beyond the absence of sanitary products, impacting girls' dignity, self-esteem, and access to education. The delegation is committed to walking alongside these girls, listening to their concerns, and providing sustainable solutions.

Shandra Johnson, an advocate for mothers and girls, highlighted the initiative's goal of ensuring girls feel supported during menstruation, emphasizing that their education matters more than their periods. Craig Bruce of Evolve Advisory Group expressed pride in supporting the humanitarian initiative and called on more partners to invest in girls' education, stating that empowering a girl empowers a community.

Dominic Obadiah, a humanitarian diplomat and founder of Civility Voice Diplomat (CvD), noted that the delegation had visited schools in both rural and peri-urban areas, where lack of sanitary products and menstrual stigma persistently hinder girls' attendance. Obadiah stressed that the mission aims to restore dignity to the girl child and ensure no girl misses school due to her period.

The delegation has donated sanitary pads and menstrual cups to hundreds of schoolgirls, introducing the latter as a reusable, environmentally friendly alternative that can last for years with proper maintenance. The outreach also focuses on educating girls about menstrual hygiene while dispelling myths and stigmas surrounding menstruation.

The program will continue in additional schools across Kenya this week, coordinated by Civility Voice Diplomat. AllAfrica, which publishes around 600 reports daily from over 90 news organizations and 500 other institutions, is responsible for the content of each report and does not edit or correct it.

Written by urgent.news from AllAfrica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at allafrica.com →

More in Health & Medicine

Innovent Biologics expands Phase 3 lung cancer trial globally

Biopharmaceutical manufacturer Innovent Biologics expanded its global Phase 3 MarsLight 11 clinical trial of candidate IBI363 TAK 928 to evaluate patients with immunotherapy resistant non squamous non…

  • Innovent Biologics expands MarsLight-11 Phase 3 lung cancer trial globally.
  • Trial now includes non-squamous non-small cell lung cancer patients.
  • IBI363/TAK-928 bispecific fusion protein assessed against docetaxel.

Kenya: Hospitals Risk Social Health Authority Lockout As Contracts

[Capital FM] Nairobi -- Healthcare providers across the country risk being locked out of the Social Health Authority (SHA) system from Thursday if they fail to complete the contracting process for the…

  • Kenya's hospitals may be locked out of SHA system from Oct 1, 2026, if contracts not finalized.
  • Existing contracts expire Sep 30, 2026, leaving providers without SHA access.
  • SHA urges providers to complete contracting process before Oct 1 deadline.

XtalPi files FDA application for intestinal pain drug candidate

Technology firm XtalPi submitted an Investigational New Drug application to the US Food and Drug Administration to initiate clinical trials for its gut restricted inhibitor KQTD 126

  • XtalPi submits FDA IND application for KQTD-126 intestinal pain drug.
  • KQTD-126 targets TRK family receptors to manage chronic intestinal pain.
  • Preclinical studies show pan-TRK inhibition at sub-nanomolar concentrations.

More from Monday 28 September →